Company news articles found here detail internal and external events that may be interesting for all stakeholders. Whether it’s CSR activities, product launches, collaborations or reports on events, you can stay up-to-date on the latest Sysmex news.
Sysmex and Inpeco announce the connection of the CN-3000/CN-6000 haemostasis analysers to the FlexLab™ Laboratory Automation System
Patient stratification and prognostic scores – the value of routine diagnostic parameters in supporting COVID-19 disease management
Die neue Ausgabe unseres Kundenmagazins xtra ist da!
Sysmex and Inpeco announce the launch of a new solution that will change the way of urinalysis
Sysmex Europe GmbH again awarded with certificate for audit berufundfamilie
Sysmex Europe GmbH among top 3 employers for IT jobs in MedTech sector
Sysmex EMEA’s first virtual congress, Sysmex Expo 2020 – a great success!
Sysmex America, Inc. attends the global AACC Annual Scientific Meeting & Clinical Lab Expo
Sysmex Obtains Manufacturing and Marketing Approval for a SARS-CoV-2 Antigen Detection Reagent
Die neue Ausgabe unseres Kundenmagazins Xtra ist da!
"Conquering the wave" – preparing for the second wave of COVID-19
Sysmex Presents Academic report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
Sysmex Europe is one of Germany's best companies for apprentices
Sysmex Europe GmbH and affiliates now distributors for Genedrive® 96 SARS-CoV-2 Kit
Sysmex Europe is celebrating 40 years of diagnostic advancement and growth
Updates & information on COVID-19
Sysmex launches next-generation fully automated blood coagulation analysers CN-6000 and CN-3000 in EMEA
Sysmex to Launch Novel Coronavirus (SARS-CoV-2) Antibody Lab Assay Service and Antibody Measurement Reagents (for Research)
The City of Kobe, Kobe City Medical Center General Hospital, and Sysmex Corporation Working to Launch from Kobe the Clinical Implementation of a New Test for the Novel Coronavirus
The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluatea SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
Sysmex Obtains First Marketing Approval in Japan for the Automated Hematology Analyzer XN-31 as a Class III Specially Controlled Medical Device to Diagnose Malaria
OSNA label extension for cervical, endometrial and prostate cancer
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
-Japanese market only-